ENDOREX CORP
8-K, EX-16.1, 2000-11-09
PHARMACEUTICAL PREPARATIONS
Previous: ENDOREX CORP, 8-K, 2000-11-09
Next: SAKS INC, 4, 2000-11-09



<PAGE>

                                                                    Exhibit 16.1


[PriceWaterhouseCoopers LLP Letterhead]



November 9, 2000



Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, DC 20549


Commissioners:

We have read the statements made by Endorex Corporation (copy attached), which
we understand will be filed with the Commission, pursuant to Item 4 of Form 8-K,
as part of the Company's Form 8-K report dated November 2, 2000. We agree with
the statements concerning our Firm in such Form 8-K. As to the last sentence of
paragraph (v), we have no basis to agree or disagree with such statement.


Very truly yours,

/s/  PricewaterhouseCoopers LLP




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission